Clinical Trial Update: A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety and tolerability of intradermal IMM-101 in adults with melanoma; the study was completed and results were posted in Decembe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• IMM 101

Snippet

Sponsor: Immodulon Therapeutics Ltd | Conditions: Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2012-12-06